Hedeker Wealth, LLC Adaptive Biotechnologies Corp Transaction History

Hedeker Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	BUY	$6.4 - $14.73 $778,668 - $1.79 Million	121,667 New	121,667 $1.06 Million
Q4 2021 Feb 01, 2022	SELL	$25.17 - $36.85 $2.96 Million - $4.33 Million	-117,500 Closed	0 $0
Q3 2021 Oct 27, 2021	BUY	$30.02 - $39.87 $3.53 Million - $4.68 Million	117,500 New	117,500 $3.99 Million
Q1 2021 May 04, 2021	SELL	$37.26 - $67.74 $4.38 Million - $7.96 Million	-117,500 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$24.95 - $48.38 $2.93 Million - $5.68 Million	117,500 New	117,500 $5.68 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $812M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Hedeker Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Hedeker Wealth, LLC with notifications on news.